ERBB2 and breast cancer: In the present study, we demonstrated for the first time that a new inflammatory score, PIV, was one of the independent predictors for pCR to NAC like the well-studied other clinicopathological factors such as T stage, ER status, HER-2 status, and Ki-67 index in breast cancer.